Polycystic ovary syndrome epidemiology and demographics: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders of reproductive-age women, with a prevalence of 4-12% in the United States. Up to 10% of women are diagnosed with PCOS.<ref name="pmid26426951">{{cite journal |vauthors=Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS |title=Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome |journal=Endocr. Rev. |volume=36 |issue=5 |pages=487–525 |year=2015 |pmid=26426951 |pmc=4591526 |doi=10.1210/er.2015-1018 |url=}}</ref> | Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders of reproductive-age women, with a prevalence of 4-12% in the United States. Up to 10% of women are diagnosed with PCOS.<ref name="pmid26426951">{{cite journal |vauthors=Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS |title=Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome |journal=Endocr. Rev. |volume=36 |issue=5 |pages=487–525 |year=2015 |pmid=26426951 |pmc=4591526 |doi=10.1210/er.2015-1018 |url=}}</ref><ref name="pmid27238627">{{cite journal |vauthors=Azziz R |title=Introduction: Determinants of polycystic ovary syndrome |journal=Fertil. Steril. |volume=106 |issue=1 |pages=4–5 |year=2016 |pmid=27238627 |doi=10.1016/j.fertnstert.2016.05.009 |url=}}</ref> | ||
==Epidemiology== | ==Epidemiology== | ||
Revision as of 14:58, 1 August 2017
|
Polycystic ovary syndrome Microchapters |
|
Differentiating Polycystic ovary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic ovary syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Polycystic ovary syndrome epidemiology and demographics |
|
FDA on Polycystic ovary syndrome epidemiology and demographics |
|
CDC on Polycystic ovary syndrome epidemiology and demographics |
|
Polycystic ovary syndrome epidemiology and demographics in the news |
|
Blogs on Polycystic ovary syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Polycystic ovary syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders of reproductive-age women, with a prevalence of 4-12% in the United States. Up to 10% of women are diagnosed with PCOS.[1][2]
Epidemiology
Prevalence
- Approximately 5% to 10% of women of reproductive age are affected
- Prevalence among first-degree relatives of patients with PCOS is 25% to 50%, suggesting a strong inheritance of the syndrome; there is evidence for possible X-linked dominant transmission
Demographics
Age
Polycystic ovary syndrome can appear anytime from menarche until menopause but generally, is seen around menarche and is diagnosed then or in early adulthood
Gender
Polycystic ovary syndrome occurs in approximately 1 in 10 women.
Race
There is no racial predilection for polycystic ovary syndrome.
References
- ↑ Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS (2015). "Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome". Endocr. Rev. 36 (5): 487–525. doi:10.1210/er.2015-1018. PMC 4591526. PMID 26426951.
- ↑ Azziz R (2016). "Introduction: Determinants of polycystic ovary syndrome". Fertil. Steril. 106 (1): 4–5. doi:10.1016/j.fertnstert.2016.05.009. PMID 27238627.